Stockscreener 앱 받기
0.83%
시간 외 거래:
Danaher Corp 주식(DHR)의 최신 뉴스
Zeno Equity Partners LLP Buys 6,856 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Kovitz Investment Group Partners LLC - MarketBeat
Journey Advisory Group LLC Sells 12,079 Shares of Danaher Corporation $DHR - MarketBeat
Fiera Capital Corp Decreases Position in Danaher Corporation $DHR - MarketBeat
CenterBook Partners LP Reduces Stock Holdings in Danaher Corporation $DHR - MarketBeat
Insider Selling: Danaher (NYSE:DHR) EVP Sells 1,320 Shares of Stock - MarketBeat
Top Analyst Reports for Philip Morris, Lockheed Martin & Danaher - Yahoo Finance
Deal Dispatch: Starboard Targets TripAdvisor, His & Hers Expands, Mister Car Wash Goes Private - Benzinga
Taxation With Representation: Freshfields, Simpson Thacher - Law360
Rx Rundown: Danaher, Johnson & Johnson, Bayer and more - Medical Marketing and Media
Danaher to Acquire Masimo Corp. for $9.9B | Business | Feb 2026 - Photonics Spectra
Leica launches CM1950 cryostat with DualEcoTec cooling system - Medical Design & Outsourcing
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Danaher to buy Masimo in $9.9 billion deal in diagnostics push - MSN
Danaher to Acquire Masimo in Transaction Valued at $9.9 Billion - Sleep Review
Promising Biotech Stocks To ResearchFebruary 19th - MarketBeat
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal - Finviz
Hemenway Trust Co LLC Sells 8,610 Shares of Danaher Corporation $DHR - MarketBeat
23,894 Shares in Danaher Corporation $DHR Purchased by Ontario Teachers Pension Plan Board - MarketBeat
King Luther Capital Management Corp Has $274.95 Million Position in Danaher Corporation $DHR - MarketBeat
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market - GlobeNewswire
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
Masimo agrees $10BN Danaher switch - Optics.org
10 Best Value Stocks to Buy for the Long Term - Morningstar
PR News | Longacre Square Works Masimo’s $10B DealWed., Feb. 18, 2026 - O'Dwyer's PR
Is It Too Late to Chase Masimo Stock on Major Danaher News? - Yahoo Finance
BofA Withdraws Rating on Masimo (MASI) Following Danaher Acquisi - GuruFocus
How Recent Developments Are Reframing The Danaher (DHR) Investment Story - Yahoo Finance
Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts - Yahoo Finance
Danaher moves to acquire Masimo in $9.9bn deal - World IP Review
Danaher’s $10 bln M&A pivot demands faith - TradingView
NEOS Investment Management LLC Buys 17,049 Shares of Danaher Corporation $DHR - MarketBeat
Danaher buys patient monitoring specialist Masimo in $9.9B deal - Fierce Biotech
Danaher to Acquire Masimo in $9.9 Billion Deal to Expand Diagnostics Portfolio - TipRanks
Masimo (MASI) climbs 34% on $9.9-billion Danaher merger - MSN
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger - Insider Monkey
Danaher stock: 3 ways Masimo deal could boost stock - Invezz
Danaher (DHR) to Acquire Masimo in $9.9 Billion Deal - GuruFocus
Masimo Stock on Pace for Record Gain After Danaher Strikes Deal - The Wall Street Journal
Danaher to acquire Masimo for $9.9 billion in cash deal By Investing.com - Investing.com South Africa
Danaher (DHR) Expands into Patient Monitoring with $9.9 Billion Acquisition of Masimo - GuruFocus
Danaher to buy Masimo in $9.9 billion deal in diagnostics push By Reuters - Investing.com Canada
This medical-devices stock is soaring. It could be in line for an acquisition. - MSN
Danaher to Acquire Masimo in $9.9 Billion Deal to Expand Diagnostics Market - NTD News
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape - The Chronicle-Journal
3 Firms Advise On $9.9B Danaher, Masimo Diagnostics Deal - Law360
Recon: Danaher to purchase Masimo for $9.9B; EU authorizes higher dose of Novo’s Wegovy - Regulatory Affairs Professionals Society | RAPS
Danaher to Buy Masimo for $180 Per Share in All-Cash $9.9 Billion Transaction - PYMNTS.com
Dow Jones Top Company Headlines at 3 PM ET: Warner Reopens Talks With Paramount After Sweetened Offer - 富途牛牛
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company. - Barron's
Danaher Corporation to Acquire Masimo Corporation - BOSS Publishing
Irvine’s Masimo selling to Danaher, Beckman Coulter owner, for $9.9 billion - San Bernardino Sun
Danaher (DHR) Experiences Unusual Bearish Options Activity - GuruFocus
Masimo: Danaher Acquisition Saves The Company From Lackluster Performance (NASDAQ:MASI) - Seeking Alpha
Danaher acquires Masimo for $9.9bn to bolster diagnostics business - Yahoo Finance
Promising Biotech Stocks Worth WatchingFebruary 17th - MarketBeat
Danaher to acquire Masimo for $9.9 billion - The Business Journals
Danaher is tapping the M&A well yet again. But we might have had enough - CNBC
Danaher (DHR) Nears Acquisition of Masimo (MASI), Stocks React - GuruFocus
Danaher Corp (DHR) Shares Down 3.5% on Feb 17 - GuruFocus
0.81%
0.78%
자본화:
|
볼륨(24시간):